These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 3804376
1. Inhibition of human monocyte respiratory burst, degranulation, phospholipid methylation and bactericidal activity by pneumolysin. Nandoskar M, Ferrante A, Bates EJ, Hurst N, Paton JC. Immunology; 1986 Dec; 59(4):515-20. PubMed ID: 3804376 [Abstract] [Full Text] [Related]
2. Activation of the oxidative burst in human monocytes is associated with inhibition of methionine-dependent methylation of neutral lipids and phospholipids. Bonvini E, Bougnoux P, Stevenson HC, Miller P, Hoffman T. J Clin Invest; 1984 Jun; 73(6):1629-37. PubMed ID: 6327766 [Abstract] [Full Text] [Related]
3. Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin. Paton JC, Ferrante A. Infect Immun; 1983 Sep; 41(3):1212-6. PubMed ID: 6885160 [Abstract] [Full Text] [Related]
4. Streptococcus pneumoniae produces a second haemolysin that is distinct from pneumolysin. Canvin JR, Paton JC, Boulnois GJ, Andrew PW, Mitchell TJ. Microb Pathog; 1997 Mar; 22(3):129-32. PubMed ID: 9075215 [Abstract] [Full Text] [Related]
5. Implication of pneumolysin as a virulence factor in Streptococcus pneumoniae endophthalmitis. Ng EW, Samiy N, Rubins JB, Cousins FV, Ruoff KL, Baker AS, D'Amico DJ. Retina; 1997 Mar; 17(6):521-9. PubMed ID: 9428015 [Abstract] [Full Text] [Related]
6. Influence of subinhibitory concentrations of protein-synthesis-inhibiting antibiotics on production and release of the pneumococcal virulence factor pneumolysin in vitro. Spreer A, von Ruden C, Mitchell TJ, Eiffert H, Nau R. Chemotherapy; 2007 Mar; 53(5):327-31. PubMed ID: 17728540 [Abstract] [Full Text] [Related]
8. Sensitivities of human monocytes and epithelial cells to pneumolysin are different. Hirst RA, Yesilkaya H, Clitheroe E, Rutman A, Dufty N, Mitchell TJ, O'Callaghan C, Andrew PW. Infect Immun; 2002 Feb; 70(2):1017-22. PubMed ID: 11796644 [Abstract] [Full Text] [Related]
9. Effect of catalase on the proliferation of human lymphocytes to phorbol myristate acetate. Sagone AL, Husney R, Guter H, Clark L. J Immunol; 1984 Sep; 133(3):1488-94. PubMed ID: 6747295 [Abstract] [Full Text] [Related]
10. Studies on the structure and mechanism of a bacterial protein toxin by analytical ultracentrifugation and small-angle neutron scattering. Gilbert RJ, Heenan RK, Timmins PA, Gingles NA, Mitchell TJ, Rowe AJ, Rossjohn J, Parker MW, Andrew PW, Byron O. J Mol Biol; 1999 Nov 12; 293(5):1145-60. PubMed ID: 10547292 [Abstract] [Full Text] [Related]
11. Rapid microtubule bundling and stabilization by the Streptococcus pneumoniae neurotoxin pneumolysin in a cholesterol-dependent, non-lytic and Src-kinase dependent manner inhibits intracellular trafficking. Iliev AI, Djannatian JR, Opazo F, Gerber J, Nau R, Mitchell TJ, Wouters FS. Mol Microbiol; 2009 Jan 12; 71(2):461-77. PubMed ID: 19040644 [Abstract] [Full Text] [Related]
12. Pneumolysin causes neuronal cell death through mitochondrial damage. Braun JS, Hoffmann O, Schickhaus M, Freyer D, Dagand E, Bermpohl D, Mitchell TJ, Bechmann I, Weber JR. Infect Immun; 2007 Sep 12; 75(9):4245-54. PubMed ID: 17562768 [Abstract] [Full Text] [Related]
13. Lung surfactant suppresses oxygen-dependent bactericidal functions of human blood monocytes by inhibiting the assembly of the NADPH oxidase. Geertsma MF, Broos HR, van den Barselaar MT, Nibbering PH, van Furth R. J Immunol; 1993 Mar 15; 150(6):2391-400. PubMed ID: 8450220 [Abstract] [Full Text] [Related]
14. Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia. Alexander JE, Berry AM, Paton JC, Rubins JB, Andrew PW, Mitchell TJ. Microb Pathog; 1998 Mar 15; 24(3):167-74. PubMed ID: 9514638 [Abstract] [Full Text] [Related]
15. Cholesterol as treatment for pneumococcal keratitis: cholesterol-specific inhibition of pneumolysin in the cornea. Marquart ME, Monds KS, McCormick CC, Dixon SN, Sanders ME, Reed JM, McDaniel LS, Caballero AR, O'Callaghan RJ. Invest Ophthalmol Vis Sci; 2007 Jun 15; 48(6):2661-6. PubMed ID: 17525197 [Abstract] [Full Text] [Related]
16. Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin. Ferrante A, Rowan-Kelly B, Paton JC. Infect Immun; 1984 Nov 15; 46(2):585-9. PubMed ID: 6389352 [Abstract] [Full Text] [Related]
17. Mechanisms of decreased antibody-dependent cytotoxicity mediated by monocytes and neutrophils in atopic dermatitis. Kragballe K, Borregaard N. Acta Derm Venereol; 1981 Nov 15; 61(1):11-15. PubMed ID: 6164208 [Abstract] [Full Text] [Related]
18. Characterisation of an oxidative response inhibitor produced by Streptococcus pneumoniae. Perry FE, Elson CJ, Mitchell TJ, Andrew PW, Catterall JR. Thorax; 1994 Jul 15; 49(7):676-83. PubMed ID: 8066562 [Abstract] [Full Text] [Related]
19. Anti-pneumolysin activity of commercially available alpha 1-antitrypsin is due to cholesterol impurities. Rubins JB, Freiberg MR. Microb Pathog; 1994 Mar 15; 16(3):221-8. PubMed ID: 8090079 [Abstract] [Full Text] [Related]
20. The effect of the pneumococcal toxin, pneumolysin on brain ependymal cilia. Mohammed BJ, Mitchell TJ, Andrew PW, Hirst RA, O'Callaghan C. Microb Pathog; 1999 Nov 15; 27(5):303-9. PubMed ID: 10547234 [Abstract] [Full Text] [Related] Page: [Next] [New Search]